Matsushita et al. (2021) demonstrated that SCFA-induced IGF-1 production from gut bacteria influences prostate cancer growth by activating local prostate MAPK and PI3K signaling pathways, thereby suggesting the existence of a gut microbiota-IGF-1-prostate axis. This evidence concerns the gene IGF1 and prostate cancer.